Ledger.Open graph →
SEC Form D · filed August 18, 2015

Editas Medicine, Inc

Offering
$120.0M
Sold
$120.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
CAMBRIDGE, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (16)

Douglas Cole · Cambridg, MADirectorKevin Bitterman · Cambridge, MADirectorAlexis Borisy · Cambrige, MADirectorKatrine Bosley · Waltham, MAExec · DirectorVic Myer · Cambridge, MAExecAlexandra Glucksmann · Cambridge, MAExecAndrew Hack · Cambridge, MAExecBoris Nikolic · Cambridge, MADirectorKatrine Bosley · Cambridge, MAExec · DirectorVic Myer · Cambridge, MAExecAlexandra Glucksmann · Cambridge, MAExecDouglas Cole · Cambridge, MADirectorKevin Bitterman · Waltham, MADirectorAndrew Hack · Cambridge, MAExecBoris Nikolic · Cambridge, MADirectorAlexis Borisy · Boston, MADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗